Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Genmab
Emory University
Children's Oncology Group
Medical University of Vienna
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center
Regeneron Pharmaceuticals
St. Jude Children's Research Hospital
Columbia University
Children's Oncology Group
M.D. Anderson Cancer Center